DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED: A COMPREHENSIVE CLINICAL AND BIOMOLECULAR LANDSCAPE OF THE NON-PONTINE TUMORS

被引：0

作者：

Mariet, Cassandra ^{[1
,2
]}

Tauziede-Espariat, Arnault ^{[2
]}

Auffret, Lucie ^{[3
]}

Ajlil, Yassine ^{[1
,3
]}

Roux, Alexandre ^{[4
]}

Pallud, Johan ^{[4
]}

Palfi, Stephane ^{[5
]}

Metais, Alice ^{[2
]}

Beccaria, Kevin ^{[6
]}

Blauwblomme, Thomas ^{[6
]}

Puget, Stephanie ^{[7
]}

Sanson, Marc ^{[8
]}

Peloux, Marie ^{[9
]}

Richard, Juliette ^{[10
]}

Thalhammer, Julian ^{[11
]}

Carvalho, Alice ^{[12
]}

Puiseux, Chloe ^{[13
]}

Pereira, Victor ^{[14
]}

de Carli, Emilie ^{[15
]}

Lesieur, Thomas ^{[16
]}

Rouger, Jeremie ^{[16
]}

Page, Philipe ^{[17
]}

Doz, Francois ^{[18
,19
]}

Bourdeaut, Franck

Dufour, Christelle ^{[1
]}

Abou, Samuel ^{[1
]}

Guerrini-Rousseau, Lea ^{[1
]}

Dhermain, Frederic ^{[20
]}

Bolle, Stephanie ^{[20
]}

Varlet, Pascale ^{[2
]}

Grill, Jacques ^{[1
,3
]}

Castel, David ^{[1
,3
]}

机构：

[1] Dept Pediat & Adolescent Oncol, Villejuif, France

[2] Hop St Anne, Dept Neuropathol, GHU Paris Psychiat & Neurosci, Paris, France

[3] Univ Paris Saclay, U981, Mol Predictors & New Targets Oncol, INSERM,Gustave Roussy, Villejuif, France

[4] Hop St Anne, Dept Neurosurg, GHU Paris Psychiat & Neurosci, Paris, France

[5] Henri Mondor Hosp, Dept Neurosurg & Intervent Neuroradiol, Creteil, France

[6] Univ Paris 05, Necker Hosp, AP HP, Sorbonne Paris Cite,Dept Pediat Neurosurg, Paris, France

[7] CHU Martinique, Dept Neurosurg, Fort De France, France

[8] Sorbonne Univ, Hop Univ La Pitie Salpetriere Charles Foix, AP HP, Serv Neurol Mazarin 2,Inserm,CNRS,Inst Cerveau &, Paris, France

[9] CHU St Denis, Pediat Oncol & Hematol Unit, St Denis, France

[10] CHU Toulouse, Hop Enfants, Dept Pediat Internal Med & Nephrol, Toulouse, France

[11] Inst Pediat Hematol & Oncol IHOPe, Leon Berard Canc Ctr, Lyon, France

[12] Ctr Hosp & Univ Coimbra, Hosp Pediat, Dept Pediat Oncol, Coimbra, Portugal

[13] Rennes Univ Hosp, Dept Pediat Oncol, Rennes, France

[14] Besancon Univ Hosp, Dept Pediat Haematol & Oncol, Besancon, France

[15] Angers Univ Hosp, Dept Pediat Haematol & Oncol, Angers, France

[16] Univ Hosp Caen, Dept Pediat Haematol & Oncol, Caen, France

[17] Univ Poitiers Hosp, Dept Neurosurg, Poitiers, France

[18] Inst Curie, SIREDO Ctr Care Innovat & Res Pediat Adolescent &, Paris, France

[19] Univ Paris Cite, Paris, France

[20] Gustave Roussy Inst, Dept Radiat Oncol, Villejuif, France

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae064.097

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

DIPG-44

引用

页数：2

共 50 条

[41] Long-term survival after cordectomy in a case of spinal cord diffuse midline glioma, H3K27-altered: illustrative case
Sato, Daisuke
Takami, Hirokazu
Tanaka, Shota
Takayanagi, Shunsaku
Ikemura, Masako
Saito, Nobuhito
JOURNAL OF NEUROSURGERY-CASE LESSONS, 2023, 6 (25):
[42] A systematic comparison of molecular features shared by H3K27-altered diffuse midline gliomas and posterior fossa A ependymomas
Pun, Matthew
Pratt, Drew
Nano, Patricia R.
Joshi, Piyush K.
Jiang, Li
Englinger, Bernhard
Rao, Arvind
Cieslik, Marcin
Chinnaiyan, Arul M.
Aldape, Kenneth
Pfister, Stefan
Filbin, Mariella G.
Bhaduri, Aparna
Venneti, Sriram
CANCER RESEARCH, 2023, 83 (07)
[43] CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand?
Power, Erica A.
Millesi, Elena
Rechberger, Julian S.
Daniels, David J.
IMMUNOTHERAPY, 2024, 16 (12) : 775 - 778
[44] Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
Donev, Kliment
Sundararajan, Vanitha
Johnson, Derek
Balan, Jagadheshwar
Chambers, Meagan
Paulson, Vera A.
Scherpelz, Kathryn P.
Abdullaev, Zied
Quezado, Martha
Cimino, Patrick J.
Pratt, Drew
Valerio, Ediel
de Castro, Joao Victor Alves
Carraro, Dirce Maria
Torrezan, Giovana Tardin
Wolff, Beatriz Martins
Kulikowski, Leslie Domenici
Costa, Felipe D'Almeida
Aldape, Kenneth
Ida, Cristiane M.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (05): : 357 - 364
[45] Genetic alteration analysis of non-pediatric diffuse midline glioma, H3 K27-altered
Jang, Hanbin
Moon, Seyoung
Kwon, Hyun Jung
Lee, Sejoon
Choe, Gheeyoung
Lee, Kyu Sang
HUMAN PATHOLOGY, 2024, 154
[46] An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice
Akdemir, Eyub Yasar
Odia, Yazmin
Hall, Matthew D.
Mehta, Minesh P.
Kotecha, Rupesh
PRACTICAL RADIATION ONCOLOGY, 2024, 14 (05) : 443 - 451
[47] H3 K27-altered diffuse midline glioma presenting as massive cerebellopontine hemorrhage
Azad, Tej D. D.
Kalluri, Anita L. L.
Hansen, Landon J. J.
Ammar, Adam
Cohen, Alan R. R.
CHILDS NERVOUS SYSTEM, 2023, 39 (08) : 2229 - 2232
[48] H3 K27-altered diffuse midline glioma presenting as massive cerebellopontine hemorrhage
Tej D. Azad
Anita L. Kalluri
Landon J. Hansen
Adam Ammar
Alan R. Cohen
Child's Nervous System, 2023, 39 : 2229 - 2232
[49] VRK3 depletion induces cell cycle arrest and metabolic reprogramming of pontine diffuse midline glioma-H3K27 altered cells
Menez, Virginie
Kergrohen, Thomas
Shasha, Tal
Silva-Evangelista, Claudia
Le Dret, Ludivine
Auffret, Lucie
Subecz, Chloe
Lancien, Manon
Ajlil, Yassine
Vilchis, Irma Segoviano
Beccaria, Kevin
Blauwblomme, Thomas
Oberlin, Estelle
Grill, Jacques
Castel, David
Debily, Marie-Anne
FRONTIERS IN ONCOLOGY, 2023, 13
[50] An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma: a new way to access innovation when clinical trials are lacking
Di Carlo, D.
Annereau, M.
Yoldjian, I.
Vassal, G.
Grill, J.
ANNALS OF ONCOLOGY, 2023, 34 (09) : 826 - 827

← 1 2 3 4 5 →